| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP,Chief Med.offr.,Drug Dev.
1 company
Hirawat Samit is an EVP,Chief Med.offr.,Drug Dev. at BRISTOL MYERS SQUIBB CO. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | BMY Bristol Myers Squibb Co | EVP,Chief Med.offr.,Drug Dev. | Buy | 4,250 | $47.58 | $202,215.00 | +5.4% | +2.2% | +22.6% | |
| Feb 14, 2025 | BMY Bristol Myers Squibb Co | EVP,Chief Med.offr.,Drug Dev. | Buy | 1,823 | $54.84 | $99,999.97 | +2.9% | -15.0% | +12.7% | |
| Nov 1, 2024 | BMY Bristol Myers Squibb Co | EVP,Chief Med.offr.,Drug Dev. | Buy | 1,830 | $54.68 | $100,055.25 | +3.0% | +8.9% | -15.2% |